Lingbo Zhang

@Lingbo_Zhang

Group Leader at Cold Spring Harbor Laboratory . and alum. My Lab studies stem cell and cancer and develops therapeutics.

Vrijeme pridruživanja: kolovoz 2015.

Tweetovi

Blokirali ste korisnika/cu @Lingbo_Zhang

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Lingbo_Zhang

  1. proslijedio/la je Tweet
    1. velj

    We’ve just put an additional, cautionary note about the use of preprints on every

    Poništi
  2. 31. sij
    Poništi
  3. proslijedio/la je Tweet
    15. sij

    This week, we've got some exciting stuff on both vitamin B6 and FLT3 inhibitors in . Don't miss out!

    Poništi
  4. proslijedio/la je Tweet

    🧬 Using , Dr. ’s lab found that the gene which produces PDXK, the enzyme that helps cells use vitamin B6, proved most important for the growth of acute myeloid .

    Prikaži ovu nit
    Poništi
  5. proslijedio/la je Tweet
    13. sij

    CSHL Fellow & collaborators at have determined just how is taking advantage of vitamin B6. In doing so, they've created an opportunity to turn the 's addiction into its weakness.

    Poništi
  6. 15. sij

    Thanks Genetic Engineering & Biotechnology News (GEN) for featuring our work from Zhang Lab and Lowe Lab - ’s Favorite Fix, B6, Vulnerable to Pharmacological Blockade via

    Poništi
  7. 13. sij

    Excited to share our discovery from Zhang Lab of B6 addition . Many thanks to the great collaboration with Lowe Lab . Many thanks to Scott, Chi-Chao, Bo and all collaborators.

    Poništi
  8. 12. sij

    It was hard working time in my lab investigating and . Nice catching up at linkedin and have a great study of biomedical science at Imperial College London .

    Poništi
  9. 8. sij
    Poništi
  10. 8. sij
    Poništi
  11. 5. sij

    is a therapeutic option for cancer and a study shows may improve overall survival of patients undergoing transfusion. Our recent study provides an alternative to target blood cell formation.

    Poništi
  12. 23. pro 2019.

    The Zhang Lab at studies and develops novel therapeutics for . From molecular biology and genetics discovery to preclinical development of therapeutic strategies, we work on the boundary between and .

    Poništi
  13. 21. pro 2019.

    My lab has identified a key regulator of blood cell self-renewal and a druggable target for blood cancer MDS and anemia. We are developing pharmacological approaches to treat these diseases that are resistant to current therapy.

    Poništi
  14. 16. pro 2019.

    Congratulations Omar for this beautiful work!

    Poništi
  15. 16. pro 2019.

    Thanks to Drug Target Review for highlighting our recent discovery on and from my lab at Cold Spring Harbor Laboratory . Thanks to Abdel-Wahab Lab for collaborating on this project.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·